A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: An application for the TEDDY (The Environmental Determinants of Diabetes in the Young) study
- Minna Kiviniemi(corresponding author),
- Robert Hermann,
- Jussi Nurmi,
- Anette G. Ziegler,
- Mikael Knip,
- Olli Simell
- University of Turku,
- Abacus Diagnostica Ltd.,
- Diabetes Research Institute,
- Klinikum Bogenhausen,
- University of Helsinki,
- Tampere University
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Background: In the TEDDY (The Environmental Determinants of Diabetes in the Young) study patient eligibility is based on the presence of some selected type 1 diabetes risk-associated human leukocyte antigen DR-DQ genotypes. A practical screening strategy was needed with efficient exclusion of ineligible patients at an early stage. Also, a simple, low-cost, and fast screening system was essential for the primary step of the risk assessment including thousands of samples. Methods: A homogeneous genotyping system utilizing an asymmetric polymerase chain reaction (PCR) and subsequent hybridization of allele-specific probes was designed to be used as the first screening step. This assay was combined with methods further elucidating the genetic risk of type 1 diabetes to screen for high-risk individuals. Results: The homogeneous assay platform allows the typing of hundreds of samples within one working day. The costs of the assay are minimal, and the reduction in hands-on time provides considerable improvements compared to the heterogeneous genotyping methods comprising separate PCR and hybridization steps. The primary selection criteria used in the first step proved to be efficient since the numbers of samples typed in subsequent stages were markedly reduced. Conclusions: The presented assay system provides a practical approach to the rapid screening of thousands of samples at low cost, a general starting point for large-scale screening studies.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 460-472 (13 pages)Journal (Volume, Issue Number)
Diabetes Technology and Therapeutics (Volume 9, Issue 5)Publication milestones
- Published - 10/01/2007
Publication status
Published - 10/01/2007
ISSN
1520-9156Publication IDs
- Scopus: 35348853966
- PubMed: 17931054
- ORCID: /0000-0002-3040-3631/work/227033615
Publication metrics
Metrics
SciVal
citations
46
SciVal
FWCI
0.93
SciVal
Author count
108
SciVal
Paper percentile
87
Fractional count
2
Fractional count
0.02
Fractional count
106
Fractional count
0.98
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Citation count
68
Captures
39
Funding Details
FunderFunding number
NIDDK
U01DK063865
